Multivalent interaction and selectivities in selectin binding of functionalized gold colloids decorated with carbohydrate mimetics by Roskamp, Meike et al.
Organic &
Biomolecular
Chemistry
Dynamic Article Links
Cite this: Org. Biomol. Chem., 2011, 9, 7448
www.rsc.org/obc PAPER
Multivalent interaction and selectivities in selectin binding of functionalized
gold colloids decorated with carbohydrate mimetics†
Meike Roskamp,a Sven Enders,b Fabian Pfrengle,a Shahla Yekta,a Vjekoslav Dekaris,a Jens Dernedde,b
Hans-Ulrich Reissiga and Sabine Schlecht*‡a
Received 12th April 2011, Accepted 26th May 2011
DOI: 10.1039/c1ob05583f
Colloidal gold particles with functionalized organic shells were applied as novel selectin binders. The
ligand shell was terminated with different monocyclic carbohydrate mimetics as simpliﬁed analogs of
the sLex unit found in biological selectin ligands. The multivalent presentation of the sulfated selectin
binding epitopes on the gold particles led to extremely high binding afﬁnities towards L- and P-selectin
and IC50 values in the subnanomolar range. Depending on the ring size of the sulfated carbohydrate
mimetic, its substitution pattern and its conﬁguration, different selectivities for either L-selectin or
P-selectin were obtained. These selectivities were not found for gold particles with simple acyclic
sulfated alcohols, diols and triols in the ligand shell. In addition, the inﬂuence of the particle size and
the thickness of the hydrophobic organic shell were systematically investigated.
Introduction
Chronic inﬂammatory diseases such as arthritis or asthma are
accompanied by ongoing extravasation of leukocytes from the
blood vessels into the inﬂammated tissue.1,2 This involves a multi-
step adhesion process initiated by different selectins and their re-
spective carbohydrate ligands on the leukocyte and on the vascular
endothelium.3 As this deregulated efﬂux of leukocytes contributes
to further tissue damage, anti-inﬂammatory therapy often aims
at inhibiting this key step. Among the natural selectin binding
ligands the P-selectin binding PSGL-1 (P-selectin glycoprotein
ligand-1) has been extensively studied. A crystal structure analysis
of the PSGL-1 peptide/P-selectin complex revealed the precise
binding of the sialyl Lewis X (sLex) unit and of two out of three
sulfated tyrosine residues presented on PSGL-1.4 The PSGL-1
peptide showed a comparable type of interaction with the L-
selectin binding pocket.5 In the course of further investigations
of P-selectin binding the tetrasaccharide sLex was considered as
the minimal binding unit required for high afﬁnity interaction
at the glycan binding site. In contrast to binding to P- and L-
selectin,where theO-glycan interaction and the binding of sulfated
tyrosin moieties is involved, the interaction of PSGL-1 with E-
selectin is achieved by the glycan binding alone and does not
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involve any sulfate units.6 Following the investigations of natural
ligands of the selectins, artiﬁcial synthetic ligands were sought for
in order to establish an anti-inﬂammatory therapy based on the
inhibition of selectin binding. Among the ﬁrst and most effective
selectin binders discovered in this way was heparin, a sulfated
glycosaminoglycan.7,8 Heparin can bind with high afﬁnity to P-
selectin and to L-selectin. At ﬁrst sight this is surprising as heparin
does not contain the sLex structuralmotif. The binding interaction
is mostly caused by the large number of sulfates presented on the
polymeric backbone in amultivalent form.The example of heparin
shows two aspects of key signiﬁcance for the future development
of selectin binders in anti-inﬂammatory therapy: (i) multivalent
presentation of binding moieties such as sulfates, (ii) minimization
of the saccharide binding units leading to less complex epitopes.
The latter is ofmajor importancewith respect to the cost and effort
entailed by the synthesis of a certain artiﬁcial selectin ligand.
Multivalent presentation of binding epitopes is a common con-
cept in ligand–receptor interactions and can result in high afﬁnities
of ligands that possess only moderate binding constants in their
monovalent form.9 A relevant synthetic example are gold particles
decorated with SDC-1721, a derivative of theHIV fusion inhibitor
TAK-779 lacking the ammonium moiety considered necessary
for efﬁcient binding. Nonetheless, multivalently presented SDC-
1721 on gold nanoparticles can bind as effectively as TAK-779
with the ammonium functionality.10 A plethora of other useful
applications of gold nanoparticles11,12 and soluble nanostructures
in general13,14 in the life sciences was invented in recent years,
many of them exploiting multivalency. Additionally, improved
multivalent ligand–receptor interactions in selectin binding were
found for multivalently functionalized dendrimers.15,16
Following the concept of simpliﬁed binding epitopes reduc-
ing the synthetic complexity of the molecules immobilized on
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nanoparticles,we prepared and immobilized a series ofmonocyclic
aminopyrans, aminofurans17 and acyclic aminopolyols as carbo-
hydrate mimetics. In order to enhance the binding afﬁnities of the
resulting gold colloids their hydroxyl groups were converted into
sulfate functionalities. The carbohydrate mimetics used here have
the advantage of being synthetically well accessible with different
substitution patterns and variable conﬁguration. In this way, it
was possible to conduct comparative studies of sulfated epitopes
of different ring size, polarity, conﬁguration, ﬂexibility and spacer
length.
Results and discussion
General aspects and syntheses
Water soluble gold colloids with a terminally functionalized thiol
shell were used as scaffolds for the multivalent presentation of
binding epitopes (Fig. 1).18 In different series of experiments the
binding epitopes A were varied for particles of different size, the
inﬂuence of the presence or absence of an amide linker B was
evaluated and the chain length of the alkyl spacer C was modiﬁed.
Fig. 1 General schematic representation of the multivalently presented
thiols containing a terminal binding epitope A, an amide linker B (might
also be absent) and an alkyl spacer C.
Core diameters of the gold colloids of 6 nm and 14 nm were
applied in these studies. These colloids can carry, depending on
the steric demand of the thiol, between about thousand and ﬁve
thousand ligands in their shell and therefore provide a high degree
of multivalency for the epitope presentation. The smaller func-
tionalized particles were obtained in a highly monodisperse form
using a recently published preparation procedure for dodecylthiol
(DT) covered colloids19 and subsequent ligand exchange (Fig. 2).
The obtained colloids with a terminal active ester (NHS-ester)
group can then be coupled to a primary amine under formation of
an amide bond yielding the epitope-containing particles (Fig. 2).
In the case of the larger gold particles with a core diameter
of 14 nm a modiﬁed citrate-route was used for the synthesis of
the particles20 and the citrate was substituted by the complete
Fig. 3 Preparation of sulfated particles from citrate-stabilized gold
colloids (14 nm) and the sodium salt of a sulfated thiolate.
functionalized ligand (mostly already in its sulfated form) that
was prepared separately (Fig. 3).
In the case of the smaller colloids where the non-sulfated
amino alcohol is coupled to the particle shell, a subsequent
sulfation is required. This can be smoothly achieved in anhydrous
dimethylformamide (DMF) as a solvent with the DMF-complex
of SO3 (Fig. 4).
Inﬂuence of the binding epitope on the selectin binding
The amino alcohols that were immobilized on the particles were
varied with respect to their size, their number of hydroxyl groups
and their polarity. Monocyclic carbohydrate mimetics in the form
of aminopyrans and aminofurans were used as cyclic binding
epitopes. Their binding ability was compared to that of acyclic
amino alcohols with one, two or three hydroxyl groups. The
substitution pattern and the conﬁguration of the aminopyrans
and aminofurans were selectively altered in order to present the
sulfated hydroxyl groups in variable spatial arrangements and to
possibly achieve a selective binding to the different binding pockets
of the different selectins. An overview of all amino alcohols that
were immobilized on the particle shell is given in Scheme 1.
Our initial experiments with immobilized amino alcohols on
the colloids were conducted with the non-sulfated form to probe
the validity of the concept of multivalent afﬁnity enhancement
of weakly binding or even non-binding epitopes. Therefore the
possible binding interaction of aminopyran 1,17,21 its N-acylated
derivative 1-t and the functionalized colloid NP-1 with P-selectin
and L-selectin was investigated in a comparative series ofmeasure-
ments in a competitive surface plasmon resonance (SPR) binding
assay.22 Unsubstituted 1 and the derivative 1-t did not show any
inhibition of selectin binding to the assay, neither for P-selectin
Fig. 2 Ligand exchange (a) and immobilization of amines (b) for the synthesis of terminally functionalized gold colloids (6 nm).
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 7448–7456 | 7449
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Fig. 4 Synthesis of sulfated colloids (6 nm) containing a carbohydrate mimetic (here compound 1).
Scheme 1 Aminopyran and aminofuran epitopes and acyclic amino alcohols.
nor for L-selectin (Table 1). In contrast, the 6 nm colloid NP-
1 was found to bind to P-selectin with an IC50 value of 10 nM.
However, no interaction with L-selectin was detected. The binding
of the multivalent colloid of 1 with P-selectin impressively shows
the ability of the presentation of a non-interacting molecule on a
particle shell to strongly enhance the binding interaction through
multivalency. Although NP-1 can give unambiguous proof-of-
principle for the effectiveness of multivalent binding, this colloid
is not very suitable for actual medical applications. The colloidal
Table 1 IC50 values for free aminopyran 1, N-acylated 1-t and function-
alized gold colloid NP-1a
Inhibitor IC50 (L-selectin) IC50 (P-selectin)
1 n. i. n. i.
1-t n. i. n. i.
NP-1 n. i. 10 nM
a n.i.: no inhibition
NP-1 is obtained as a slightly milky solution with limited stability.
After a few hours it develops a tendency to ﬂocculate. This is
followed by quick precipitation even when the product has been
stored in the dark.
Because of the limited colloidal stability ofNP-1 and the known
improvement of selectin binding for sulfated epitopes we studied
the sulfated analogue NP-1-sulf for comparison. After sulfation
of NP-1, the resulting NP-1-sulf showed excellent solubility and
stability in its colloidal state. The negative charge of the sulfate
groups on the stabilizing shell causes interparticle repulsion and a
loss of all tendency towards agglomeration. When the selectin
binding properties of NP-1-sulf were evaluated, binding to L-
selectin and P-selectin was found for the sulfated colloid. Both IC50
values are lower than that forNP-1 by several orders ofmagnitude.
For P-selectin a value of 0.04 nM was measured whereas the L-
selectin binding revealed an IC50 of 0.35 nM (Table 2). In both
cases the IC50 value was signiﬁcantly lower than the respective
IC50 value of heparin of 12 mM for L-selectin. The tendency
of NP-1 to show a stronger interaction with P-selectin is also
7450 | Org. Biomol. Chem., 2011, 9, 7448–7456 This journal is © The Royal Society of Chemistry 2011
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Table 2 IC50 values for sulfated functionalized gold colloids (6 nm)
carrying aminopyran epitopes
inhibitor IC50 (L-selectin) IC50 (P-selectin)
NP-1-sulf 0.35 nM 0.04 nM
NP-2-sulf 0.90 nM 0.20 nM
NP-3-sulf 0.55 nM 0.13 nM
NP-4-sulf 0.60 nM 0.12 nM
NP-5-sulf 0.20 nM 0.46 nM
NP-6-sulf 0.12 nM 0.30 nM
found for its sulfated derivative and this seems to point at a
selectivity for the binding pocket of this selectin. The excellent
IC50 values obtained for NP-1-sulf demonstrate that the applied
monocyclic carbohydrate mimetic can be a sufﬁciently complex
epitope for very effective selectin interaction. Therefore, we tested
a series of other monocyclic amino polyols with ﬁve-membered
and six-membered rings (Scheme 1) in their sulfated form. Six
different aminopyrans and two aminofurans were immobilized on
the 6 nm gold colloids, sulfated and evaluated with respect to
their selectin binding properties. They all showed IC50 values in
the sub-nanomolar range and moderate selectivities for either P-
or L-selectin (Table 2).
In the case of NP-1-sulf, NP-2-sulf, NP-3-sulf and NP-4-
sulf the selectivity is in favor of P-selectin, whereas NP-5-sulf
and NP-6-sulf preferentially bind to L-selectin. The applied
sulfated aminopyrans differ in their substitution pattern at the
six-membered ring, but also in the number of sulfate groups they
present to the selectins when bound to the particle. As can be seen
from the values of NP-5-sulf and NP-6-sulf the selectivity is not
controlled by the number of sulfates per ring. A replacement of
the gem-dimethyl substitution at C1 in 1 and 2 by a single methoxy
group at this carbon atom in 3 and 4 does not change the selectivity
for P-selectin either. Compounds 3 and 4 are enantiomers, but
this stereochemical relationship has almost no inﬂuence on the
IC50 values when these two epitopes are connected to the gold
colloids and presented in a multivalent fashion. It rather seems
to be the relative stereochemical orientation between the amino
substituent at C4 used for immobilization and its neighboring
sulfates. The aminopyrans 1–4 all have a trans-trans conﬁguration
of the amino group and the adjacent sulfate substituents at C3
and C2. In contrast, the aminopyrans 5 and 6 do not show this
conﬁgurational pattern at C2 to C4. After the immobilization and
the formation of the amide bond the sulfated heterocycles have
to ﬁnd their best possible conformation for the dense coverage of
the colloid surface. The resulting accessibility of the sulfate groups
for the different selectins will therefore vary characteristically for
different substitution patterns and preferred conformations. The
conformation and the orientation of the sulfate groups of NP-
1-sulf to NP-4-sulf is apparently more suitable for binding to P-
selectin, whereas the colloids presenting the sulfated aminopyrans
5 and 6 exhibit a stronger interaction with L-selectin.
In addition to the binding studies with colloids carrying sulfated
aminopyrans, we also investigated the binding properties of two
immobilized and sulfated aminofurans 7 and 8. Sulfated 7 contains
a trans-trans substitution pattern similar to aminopyrans 1–4,
whereas the aminofuran 8 does not contain the primary amino
group directly at the ring. These structural features lead to slightly
Table 3 IC50 values for sulfated functionalized gold colloids (6 nm) with
aminofurans
Inhibitor IC50 (L-selectin) IC50 (P-selectin)
NP-7-sulf 0.20 nM 0.14 nM
NP-8-sulf 0.15 nM 0.40 nM
better P-selectin binding for NP-7-sulf and a moderate L-selectin
selectivity for NP-8-sulf (Table 3).
Summarizing the binding experiments with functionalized gold
colloids presenting sulfated aminopyrans and aminofurans, it can
be stated that all particles with carbohydrate mimetic epitopes
show excellent potential for an inhibition of the binding of P- and
L-selectin to their natural ligands. In all cases IC50 values in the
sub-nanomolar range were found and the sulfated colloids were
stable at least for several months. As these data clearly indicate
that the approach using a simpliﬁed carbohydrate mimetic epitope
presented in a highly multivalent manner on a gold colloid is well
suited to obtain high-afﬁnity selectin interactions, we attempted
to reduce the immobilized chemical structures even further and
functionalized the colloidswith simple acyclic aminopolyols. After
their attachment to the particle shell they were sulfated like the
heterocyclic systems discussed above.
The coupling of amino alcohols with one, two or three hydroxyl
groups was achieved by the formation of an amide bond from
an NHS ester as described for the cyclic analogues. Complete
sulfation of the product colloids was again obtained by reaction
with SO3·DMF. The IC50 values for binding to P-selectin and
L-selectin for a series of four different sulfated colloids were
measured (Table 4).
The functionalized gold colloids with acyclic epitopes also show
excellent binding to both selectins in the sub-nanomolar range, in
some cases with even lower IC50 values than the cyclic compounds.
But in contrast to the sulfated aminopyrans and aminofurans all
acyclic epitopes exhibited no signiﬁcant selectivity in their binding
behavior towards the two tested selectins. When the values of the
monosulfate NP-9-sulf, the disulfate NP-10-sulf and the trisulfate
NP-11-sulf are compared the strongest binding is found for NP-
10-sulf derived from the aminodiol serinol. For the disulfate the
charge density on the surface of the colloid shell and the ﬂexibility
of the epitope seem to be ideal for interaction with the binding
pocket. Colloids covered with a monosulfate bind more weakly,
most likely because of the smaller number of sulfate groups
available in their shell. Unlike the disulfate case, the trisulfated
amino alcohol does not improve the IC50 values. A possible
reason might be the high steric demand of the trisulfate, reducing
the packing density of the ligand shell and creating more steric
hindrance in the binding pocket. When the phenyl-substituted
NP-12-sulf was investigated in order to check the inﬂuence of
the bulky apolar substituent, an even bigger negative impact on
Table 4 IC50 values for sulfated functionalized gold colloids (6 nm)
carrying different acyclic epitopes
Inhibitor IC50 (L-selectin) IC50 (P-selectin)
NP-9-sulf 0.18 nM 0.22 nM
NP-10-sulf 0.02 nM 0.03 nM
NP-11-sulf 0.07 nM 0.09 nM
NP-12-sulf 0.10 nM 0.15 nM
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 7448–7456 | 7451
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Table 5 IC50 values for sulfated functionalized 6 nm and 14 nm gold
colloids
Inhibitor IC50 (L-selectin)
NP-9-sulf (6 nm) 0.18 nM
NP-13-sulf (14 nm) 0.13 nM
NP-10-sulf (6 nm) 0.02 nM
NP-14-sulf (14 nm) 0.07 nM
NP-11-sulf (6 nm) 0.07 nM
NP-15-sulf (14 nm) 0.20 nM
the IC50 values was detected. Here, the steric hinderance and the
hydrophobicity of the phenyl group are both of disadvantage.
Although we observe a lack of selectivity in the binding of these
acyclic sulfates, the colloid-selectin interaction is strong and there
is a tendency for generally lower IC50 than for the cyclic analogues.
The consistently good selectin binding properties of the in-
vestigated colloids of 6 nm core size asked for an evaluation
of similarly functionalized gold particles with a larger core
diameter. As already mentioned earlier, these larger particles
with functionalized ligand shells (NP-13-sulf to NP-15-sulf) were
obtained by direct ligand exchange from citrate stabilized particles
of 14 nm core diameter (Scheme 2, Fig. 3). Only sulfated colloids
with acyclic amino alcohols were prepared for this purpose and
their values for L-selectin bindingwere comparedwith the ones for
6 nm colloids with the same type of functionalized shell (Table 5).
The effect of the particle size on the selectin interaction is
different for the immobilized monosulfate and for the di- and
trisulfates. When the monosulfate is used, the bigger particle
size leads to a slightly improved selectin interaction, whereas
the disulfate and the trisulfate show higher IC50 values when
the bigger colloids are used. A possible explanation for this
phenomenon can be found in the higher packing density of the
ligand shell when the curvature is reduced due to the larger particle
diameter. The average distance between the terminal binding
Table 6 IC50 values for amide-containing NP-9-sulf (6 nm) and amide-
free NP-16-sulf (6 nm)
Inhibitor IC50 (L-selectin) IC50 (P-selectin)
NP-9-sulf 0.18 nM 0.22 nM
NP-16-sulf 0.15 nM 0.03 nM
epitopes becomes smaller for larger colloids. This was shown in
previouswork on particles covered by a dodecylthiol shell23 and on
DNA-functionalized particles.24 For the bulkier di- and trisulfated
systems no further densiﬁcation of the thiol shell is possible and
the reduced curvature of the bigger particles causes a loss of thiols
from the particle rather than a denser packing of the shell. As a
consequence, the selectin binding is weakened compared with the
smaller colloids.
Inﬂuence of the amide linker on the selectin binding
As the binding pocket of the respective selectin is prone to
polar interaction with the amide bond created in the coupling
of the amino alcohol to the particle shell, a comparison of NP-
9-sulf with NP-16-sulf bearing no amide bond reveals signiﬁcant
differences (Table 6). Although the amide bond is not directly
solvent-exposed, its presence has a clear impact on the IC50 values.
The amide-free colloid NP-16-sulf shows a similar binding afﬁnity
to L-selectin as the amide-containing NP-9-sulf, but its IC50 value
for P-selectin is considerably reduced, thus creating a selectivity
between the two selectins that is not observed for any of the amide-
coupled acyclic sulfate colloids. It was pointed out in recent work
on the interaction of the natural ligand PSGL-1 with P- and L-
selectin and the arrangement of the ligand in the bindingpockets of
these selectins that hydrophobic interactions between leucine and
proline residues of PSGL-1 and the selectin play an important role
for P-selectin but could not be found forL-selectin binding.25 Thus,
Scheme 2 Functionalized sulfated colloids NP-13-sulf to NP-18-sulf obtained by direct ligand exchange from Au/dodecanethiol (6 nm) or Au/citrate
(14 nm).
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the very low IC50 value found for P-selectin binding of NP-16-sulf
can be attributed to a hydrophobic interaction of the alkyl chain
within the binding pocket of P-selectin. The presence of the polar
amide bond in the thiol shell seems to disturb this interaction
and therefore leads to a higher IC50 value. It is remarkable that
this selectivity is only found for the colloid NP-16-sulf. The
monovalent sulfated 11-mercapto-undecanol 16-sulf showed no
selectivity and much higher IC50 values of 30 mM and 40 mM for L-
and P-selectin, respectively.When comparing the IC50 values for P-
selectin binding of monovalent 16-sulf and multivalent NP-16-sulf
it becomes apparent thatmultivalent presentation of such epitopes
on a gold nanoparticle can enhance their biological activity by a
factor of up to 106.
Inﬂuence of the chain length of the alkyl spacer
Aiming at a broader understanding of the parameters involved in
the selectin binding of these colloids, we conducted an additional
series of experiments varying the chain length of the thiol shell of
14 nm colloids. This will alter the packing density of the epitopes
presented on the particle and the degree of the hydrophobic
interaction with P-selectin. The thiols used for this study were
derived from hexanoic acid, octanoic acid and undecanoic acid
(Scheme 2, Table 7). A ﬁrst tendency found in the data is a stepwise
improvement of selectin afﬁnities in variation with the length of
the alkyl chain. BothL- and P-selectin prefer colloids with a longer
alkyl chain, but the differences in the IC50 values between the C6
chain and the C11 chain are much greater for P-selectin. This is
not particularly surprising as the hydrophobic interaction that is
already weak because of the amide bond is expected to almost
disappear for a short chain. Therefore the IC50 value for P-selectin
found for NP-17-sulf is 5.4 times higher than for NP-14-sulf, but
for L-selectin it is only 2.3 times more. As a consequence, the
colloid with the short chain C6 thiol shows a moderate selectivity
for L-selectin.
Table 7 IC50 values for sulfated functionalized gold colloids (14 nm) with
different chain lengths of the spacer molecules of the shell
Inhibitor IC50 (L-selectin) IC50 (P-selectin)
NP-17-sulf 0.16 nM 0.54 nM
NP-18-sulf 0.07 nM 0.13 nM
NP-14-sulf 0.07 nM 0.10 nM
Non-toxicity of the colloids towards Jurkat cells
Given the excellent stability and the very high binding afﬁnity
of the sulfated colloids, their possible cytotoxicity towards L-
selectin-expressing T-cells was also investigated. All leukocytes
constitutively express L-selectin on their cell surface and are there-
fore targets for the here described functionalized gold colloids.
Because of their general importance in immunosurveillance we
chose a T-cell line (Jurkat) for toxicity studies to show if cellular
binding of ligands does interfere with cell proliferation. The three
differently functionalized colloids NP-1-sulf, NP-10-sulf and NP-
16-sulf were evaluated. Jurkat cells were incubated with colloid
solutions in the concentration range from 0.003 nM to 30 nM
(Fig. 5). In all cases the cell viability was not reduced. Although
the colloids did not show acute toxicity, further analyses are
Fig. 5 Cell viability of Jurkat cells after incubation with different sulfated
functionalized colloids.
necessary to prove for safety in animalmodels, also in longitudinal
comparative studies. High speciﬁty of gold colloids decorated with
carbohydrate mimetics to L- and P-selectin and fast clearance of
unbound particles in vivo are desirable in order to avoid unwanted
side effects. As reviewed recently29 local and systemic toxicity of
nanoparticles is determinedbyparticle composition, dose, size and
surface characteristics. In this respect it is noteworthy that citrate-
capped gold nanoparticles, even after repeated administration to
mice and accumulation in tissues, showed no obvious toxicity.30
We are therefore conﬁdent for further developments and that
the colloids show promise for future application for therapeutic
purposes.
Conclusions
Several series of sulfated cyclic and acyclic amino alcohols
presented at gold colloids of different size were prepared and
evaluated as multivalent selectin binding agents. All sulfated
colloids showed very low IC50 values in the subnanomolar range
for binding to P- and L-selectin. It was found that the chain
length of the protective shell and the presence or absence of an
amide bond in the spacermolecules considerably affect the binding
properties of the particles. Binding to P-selectin is improved in the
absence of an amide bond and for longer alkyl chains in the shell.
When compared to acyclic sulfated epitopes which do not
differentiate between P-selectin and L-selectin, sulfated cyclic
carbohydrate mimetics showed a clear selectivity for either P- or
L-selectin. Preferential binding to P-selectin was always found
when a trans-trans arrangement of the amino group at C4 of the
aminopyran and the sulfate substituents at C2 andC3was present.
Accordingly, amoderate selectivity for P-selectinwas found for the
aminofuranwith trans-trans conﬁguration of the amino group and
the substituents at C1 and C2.
For the series of colloids with acyclic epitopes the best binding
properties were found for the disulfated serinol independent of the
particle size. Here, an optimum in the interplay of surface charge
and ligand ﬂexibility seems to exist.
Functionalized gold colloids with multivalently presented sul-
fated polyol epitopes show excellent selectin binding properties
and no signs of cytotoxicity. In addition, they are a valuable
conceptional example for a signiﬁcant improvement of ligand–
receptor interactions when the ligand is presented in a multivalent
fashion.
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 7448–7456 | 7453
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Experimental section
All reactions in aqueous solution were conducted in puriﬁed
Millipore water. Organic solvents were distilled before use with
the colloids. All other chemicals were purchased from commercial
sources and used as received.
Aminopyran derivatives and aminofuran derivatives were pre-
pared as described earlier: 1 and 2,21 3 and 4,26 5 and 6,27 7 and
8.28
NMRspectrawere recordedwith a JEOL lambda 400 spectrom-
eter, IR spectra were obtained on a Nicolet 5 SXC spectrometer in
ATR mode. SPR measurements were performed on a BIACORE
X instrument.
Because of the rigidity of the alkyl chains in the thiol shells and
the resulting large differences in the relaxation times of different
protons, no integrals are given for the proton NMR data of the
colloids.
Synthesis of Au/dodecanethiol
An amount of 0.435 g (5.00 mmol) of tert-butylamin-borane com-
plex was added to a solution of 0.247 g Au(PPh3)Cl (0.50 mmol)
and 0.25 ml dodecanethiol (1.00 mmol) in 40 ml of benzene.
The mixture was stirred at 55 ◦C for 1 h before cooling to room
temperature. Then 40ml of ethanol were added and the precipitant
separated by centrifugation. The black solid powder was washed
with ethanol at least three times, dried under vacuum, and resolved
in 25 ml of chloroform.
Synthesis of Au/citrate
A solution of 34 mg (0.09 mmol) of HAuCl4·3 H2O in 360 ml of
water was heated to reﬂux for 20 min. Under vigorous stirring a
solution of 187mg (0.52mmol) of sodium citrate in 1.8ml of water
was added quickly. The reaction mixture was held under reﬂux for
3 h. Then the solution was cooled to 0 ◦C in an ice bath and
ﬁltered (0.2 mm pore size). A clear violet solution with a particle
concentration of 2.6 nM was obtained and stored at 0 ◦C.
Synthesis of Au/MUDHSE
An amount of 95 mg of N-hydroxysuccinimid-11-
mercaptoundecanoate (MUDHSE) (0.60 mmol) was dissolved
in anhydrous dimethylformamide (DMF) and 1 ml of a 3 mM
solution of dodecanethiol-protected gold nanoparticles in
chloroform was added dropwise to the stirring solution. After
15 min the main part of the chloroform was removed under
reduced pressure and the solution was stirred at r.t. for another
24 h. The nanoparticle solution was dialysed against 400 ml
DMF three times, dried under vacuum and resolved in 15 ml of
anhydrous DMF.
Three representative synthetic procedures for the preparation
of the sulfated colloids are presented here: amine immobilization
and subsequent sulfation forNP-1-sulfwith a cyclic epitope, amine
immobilization and sulfation forNP-9-sulfwith an acyclic epitope
and direct ligands substitution with the sulfated thiol for NP-17-
sulf. Synthetic procedures for all other functionalized colloids can
be found in the Supporting Information.
Synthesis of gold nanoparticles bearing aminopyran 1 (NP-1)
A solution of 4.2 mg 1 (0.02 mmol) in anhydrous DMF was
added to 5 ml of a 0.2 mM solution of MUDHSE protected gold
nanoparticles in DMF. After 30 min of stirring at r.t. 20 ml of
triethylamine (0.14 mmol) was added and the mixture stirred for
another 24h.The clear colloid solutionwasdialysed against 300ml
of DMF for three times, dried under vacuum and resolved in 5 ml
of anhydrous DMF.
Sulfation of NP-1 (NP-1-sulf)
At 0 ◦C 15.3 mg SO3·DMF complex (0.10 mmol), dissolved in
1 ml of anhydrous DMF, was slowly dropped to 10 ml of a 0.1 mM
solution of NP-1 in anhydrous DMF. After 24 h of stirring at
r.t. the clear solution was dialysed against 300 ml of DMF for
one time and 300 ml of triple-distilled water for three times. For
storage the colloid solutionwas diluted to a 0.03mMconcentration
of nanoparticles.
1H NMR (D2O, 400 MHz): d = 1.30 (bs), 1.32 (s), 1.47 (s), 1.59
(m), 1.68 (m), 2.30 (bt), 2.39 (q), 2.76 (bs), 4.01 (m), 4.18 (m), 4.46
(m), 4.54 (m).
ATR-IR: n = 3448 cm-1 (w, n(N–H)), 3075 (w), 2923 and 2852 (s,
n(C–H)), 2484 (w), 1687 and 1647 (s, n(C O)), 1529 (s, d(N–H)),
1467 and 1207 (s, R–O–SO2–OR¢), 1058 (s), 985 (s), 810 (s), 582
(s).
Synthesis of gold nanoparticles bearing ethanolamine 9 (NP-9)
A solution of 9 ml ethanolamine 9 (0.15 mmol) in anhydrous DMF
was added to 5 ml of a 0.2 mM solution of MUDHSE-protected
gold nanoparticles in DMF. After 30 min of stirring at r.t. 20 ml
triethylamine (0.14 mmol) was added and the mixture stirred for
another 24h.The clear colloid solutionwasdialysed against 300ml
of DMF for three times, dried under vacuum and resolved in 5 ml
of anhydrous DMF.
Sulfation of NP-9 (NP-9-sulf)
At 0 ◦C 300 mg SO3·DMF-complex (1.96 mmol), dissolved in
1 ml of anhydrous DMF, was slowly dropped to 10 ml of a 0.1 mM
solution of NP-9 in anhydrous DMF. After 24 h of stirring at
r.t. the clear solution was dialysed against 300 ml of DMF for
two times and 300 ml of triple-distilled water for three times. For
storage the colloid solutionwas diluted to a 0.03mMconcentration
of nanoparticles.
1H NMR (D2O, 400 MHz): d = 1.25 (bs), 1.56 (bs), 2.22 (bs),
2.69 (bs), 3.45 (bs), 4.06 (bs).
ATR-IR: n = 3302 cm-1 (s, n(N–H)), 2918 and 2850 (s, n(C–H)),
1686 and 1639 (s, n(C O)), 1532 (s, d(N–H)), 1465–1452 and
1211 (s, R–O–SO2–OR¢), 1066 (s), 1020 (s), 959 (w), 719 (s), 579
(s).
Synthesis of 6-acetylsulfanylhexanoic acid
An amount of 1.50 g (7.67 mmol) of 6-bromohexanoic acid was
dissolved in 15 ml of anhydrous DMF. A solution of 1.32 g
(11.50mmol) of potassium thioacetate in 15ml ofDMFwas added
dropwise and the mixture was stirred for 1 h. The solvent was
removed under vacuum and water was added to the residue. Then
the product was extracted with CH2Cl2 repeatedly. The organic
7454 | Org. Biomol. Chem., 2011, 9, 7448–7456 This journal is © The Royal Society of Chemistry 2011
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phases were collected and the solvent was removed under vacuum.
The product was dried and 1.06 g (72% yield) of the product were
obtained.
1H NMR (CDCl3, 400 MHz): d = 1.35–1.45 (m, 2H), 1.57 (quin,
2H), 1.63 (quin, 2H), 2.30 (s, 3H) 2.33 (t, 2H), 2.85 (t, 2H).
Synthesis of N-hydroxysuccinimide-6-acetylsulfanylhexanoate
An amount of 1.06 g (5.58 mmol) of 6-acetylsulfanylhexanoic
acid was added to a solution of 708 mg (6.16 mmol) of N-
hydroxysuccinimide in 100 ml of CH2Cl2. A solution of 1.27 g
(6.16 mmol) of dicyclohexylcarbodiimide (DCC) in 5 ml of
CH2Cl2 was added dropwise and after a few minutes a white solid
precipitated. The reaction mixture was stirred for 1 h. The solvent
was removed under vacuum and the crude product was dissolved
in little CH2Cl2 and ﬁltered. The solvent was evaporated and 1.55 g
of a brownish oil were obtained (98% yield).
1H NMR (CDCl3, 400 MHz): d = 1.46 (m, 2H), 1.61 (quin, 2H),
1.74 (quin, 2H), 2.30 (s, 3H), 2.59 (t, 2H), 2.82 (s, 4H), 2.86 (t, 2H).
Synthesis of [5-(2-hydroxy-1-hydroxymethyl-ethylcarbamoyl)-
pentyl]-S-thioacetate
Anamount of 765mg (8.41mmol) of serinol 10was added to 20ml
of a solution of 1.62 g (5.64 mmol) of N-hydroxysuccinimide-6-
acetylsulfanylhexanoate in DMF. After a few minutes the solution
became cloudy and the mixture was stirred for 30 min. The solvent
was removed under vacuum and the residue was suspended in
50 ml of water. The suspension was stored over night at 4–8 ◦C.
The white precipitate was ﬁltered off, washed with water, dried
under high vacuum and puriﬁed by chromatography (CH2Cl2). A
white solid was obtained (448 mg, 30% yield).
1H NMR (CDCl3, 400 MHz): d = 1.34 (quin, 2H), 1.55 (quin,
2H), 1.62 (quin, 2H), 2.19 (t, 2H), 2.29 (s, 3H), 2.82 (t, 2H), 3.72
(ddd, 4H), 3.92 (quin, 1H).
Synthesis of 17-sulf
[5-(2-Hydroxy-1-hydroxymethyl-ethyl-carbamoyl)pentyl]-S-thio-
acetate (52 mg, 0.20 mmol) was dissolved in 2 ml of DMF
and 123 mg (0.80 mmol) of SO3·DMF in 1 ml of DMF were
added dropwise. The solution was stirred for 1 h. 3.2 ml of 1 M
NaOH were added and the reaction mixture was stirred for 5 h.
The completeness of the reaction was monitored by TLC. The
product was not isolated but directly reacted with the Au/citrate
nanoparticles.
Synthesis of NP-17-sulf
A solution of 0.20 mmol 17-sulf in 6 ml of DMF/NaOH was
added to 50 ml of a 2.6 nM aqueous solution of Au/citrate and
the mixture was stirred for 72 h. Then the particles were dialysed
against 600 ml of water for three times. After concentration of the
solution to 10 ml a 12.7 nM solution of NP-17-sulf was obtained.
1H NMR (D2O, 400 MHz): d = 1.37 (m), 1.59 (m), 1.66 (m), 2.26
(t), 2.71 (m), 4.09 (m), 4.38 (m).
SPR based competitive selectin-ligand binding assay22
Selectin-ligand binding was analyzed by surface plasmon reso-
nance (SPR). First, the binding (detected as resonance units) of
selectin-coated nanoparticles to a selectin ligand, immobilized on
a sensor chip, was tested, and the resulting signal was henceforth
referred to as 100% binding. Pre-incubation of the selectin-coated
particles with varying concentrations of a selectin inhibitor (here a
gold colloid with a ligand shell) decreased the binding signal. The
calculated IC50 values (half inhibitory concentration) is the molar
concentration of the inhibitor needed to reduce the binding signal
to 50% of the initial value. Further details regarding the binding
assay can be found in the ESI† and in Ref. 22.
Cytotoxicity assay
The Promega CellTiter 96R© AQueous Cell Proliferation Assay was
applied. L-selectin expressing T-cells (Jurkat) cells were seeded in
96-well plated at a density of 5000 cells/well. The Au-colloids NP-
1-sulf, NP-10-sulf and NP-16-sulf were added at concentrations of
0.003 nM, 0.03 nM, 0.3 nM, 3 nM and 30 nM. In comparison to
the untreated control cell proliferation was detected after 3 days
incubation by measuring the conversion of the tetrazolium com-
pound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS) andan electron coupling
reagent, phenazine ethosulfat (PES) into awater-soluble formazan
that absorbs light at 490 nm by cellular dehydrogenases. The assay
was performed in triplicates at each concentration. The untreated
control was set to 100% proliferation.
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